
|Articles|November 15, 2002
IOP-lowering agents evaluated in real-world setting
Pittsburgh-IOP-lowering products evaluated in the "real-world" setting of a clinical practice can provide valuable information for practitioners, according to Evan B. Dreyer, MD, PhD.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection
2
FDA guidance to help accelerate cell and gene therapies
3
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
4
Study links alcohol consumption to earlier advanced presbyopia in men
5





















